Max S. Wicha

Founder at University of Michigan - Rogel Cancer Center

Max S. Wicha

Max S. Wicha

Founder at University of Michigan - Rogel Cancer Center

Overview
Career Highlights

University of Michigan - Rogel Cancer Center
OncoMed Pharmaceuticals, Inc.

RelSci Relationships

1089

Number of Boards

3

Relationships
RelSci Relationships are individuals Max S. Wicha likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founding Member at Whitehead Institute for Biomedical Research

Relationship likelihood: Strong

Director & Chief Scientific Officer at Jiangsu Yasheng Pharmaceutical Development Co. Ltd.

Relationship likelihood: Strong

Chief Executive Officer & Director at Verastem, Inc.

Relationship likelihood: Strong

Chair, Department of Radiation Oncology at University of Michigan Medical School

Relationship likelihood: Strong

President & Chief Executive Officer at Cold Spring Harbor Laboratory

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Van Andel Institute

Relationship likelihood: Strong

Director & CIO at Van Andel Institute

Relationship likelihood: Strong

Chief Operations Officer at Van Andel Institute

Relationship likelihood: Strong

Co-Founder at Revolution Medicines, Inc.

Relationship likelihood: Strong

Founder at PJT Partners, Inc.

Relationship likelihood: Strong

Paths to Max S. Wicha
Potential Connections via
Relationship Science
You
Max S. Wicha
Founder at University of Michigan - Rogel Cancer Center
Education
Medical Degree

A leader in the Biomedical Revolution, Stanford Medicine has a long tradition of leadership in pioneering research, creative teaching protocols and effective clinical therapies. Our close proximity to the resources of the university—including the Schools of Business, Law, Humanities and Sciences and Engineering—our seamless relationship with our affiliated adult and children’s hospitals and our ongoing associations with the entrepreneurial endeavors of Silicon Valley make us uniquely positioned to accelerate the pace at which new knowledge is turned into tangible health benefits.

Career History
Professor, Medical Oncology
1980 - Current

University of Michigan founded its medical school in 1850, it immediately assumed a leadership role in American academic medicine. Medical School was the University's first professional school, and since graduating its first class of six students in 1851 a group which paid a mere $5 for two years of medical education. They have become a leader in preparing the physicians and scientists of the future.

Co-Founder
Prior

OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA.

Boards & Committees
Member, Scientific Advisory Board
Current

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$6.5M
2016

The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice.

Political Donations
Investments
Details Hidden

OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Max S. Wicha. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Max S. Wicha's profile does not indicate a business or promotional relationship of any kind between RelSci and Max S. Wicha.